VERA

Vera Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Fordyce MarshallDirector, Officer: PRESIDENT AND CEO
$237k5.7k shares
SellJan 8, 2025
$42.03
--
Fordyce MarshallDirector, Officer: PRESIDENT AND CEO
$79k1.9k shares
SellJan 8, 2025
$42.00
--
Fordyce MarshallDirector, Officer: PRESIDENT AND CEO
$414k10k shares
SellJan 8, 2025
$41.53
--
Fordyce MarshallDirector, Officer: PRESIDENT AND CEO
$31k1.1k shares
SellFeb 26, 2025
$28.32
--
Fordyce MarshallDirector, Officer: PRESIDENT AND CEO
$220k8k shares
SellFeb 26, 2025
$27.55
--
Fordyce MarshallDirector, Officer: PRESIDENT AND CEO
$296k10.6k shares
SellFeb 21, 2025
$27.89
--

News

globenewswire.comVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 5247wallst.com$20 Billion: Inside Nvidia's VERA CPU Bet to Break the Intel-AMD Duopoly247wallst.comJun 4globenewswire.comVera Therapeutics Announces Alignment with U.S. FDA on Earlier ORIGIN Phase 3 Analysis to Support Potential Full Approval for Atacicept in Adults with IgA Nephropathyglobenewswire.comJun 2fool.comInvestment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filingfool.comMay 26globenewswire.comVera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comMay 8